Reaction
Immune Thrombocytopenia reporting signals
As of the last recalculation, Immune Thrombocytopenia appears in 4,416 FAERS reports alongside 197 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 80.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.